Literature DB >> 16085541

Donor hematopoietic cells from transgenic mice that express GFP are immunogenic in immunocompetent recipients.

Simon J Bubnic1, Andras Nagy, Armand Keating.   

Abstract

OBJECTIVE: To study the immunogenicity of hematopoietic cells marked with green fluorescence protein (GFP) while avoiding the potentially confounding effects of viral gene transduction, marked cells from GFP+ transgenic mice were tracked after transplantation into unconditioned immunocompetent recipients.
MATERIALS AND METHODS: Marrow was harvested from GFP+ transgenic mice that had been crossed onto a BALB/cByJ background. Unconditioned marrow transplantation involved infusion of sex-matched or sex-mismatched cells into female BALB/cByJ hosts. Engraftment and contribution to circulating nucleated blood cells were compared to recipients of donor cells that were not GFP-marked. Donor cells were detected by flow cytometry (GFP) and fluorescence in situ hybridization (FISH) for Y-chromosome sequences.
RESULTS: Donor cells from mice of the same genetic background that did not express GFP were detected for more than four-weeks in unconditioned recipients. In contrast, GFP-marked cells in the blood peaked at one-week, declined to undetectable levels by two-weeks and were not detected in the marrow at sacrifice. In sex-mismatched studies, detection of male GFP+ donor cells by FISH yielded levels similar to those observed by flow cytometry, in contrast to the levels detected for many weeks in mice infused with male cells that did not express GFP. In immunocompetent recipients immunized with irradiated GFP-expressing cells, rechallenge with GFP+ cells resulted in the accelerated loss of donor cells.
CONCLUSION: Donor marrow cells from GFP+ transgenic mice were lost after infusion into unconditioned immunocompetent mice and sensitization studies infer an immunologic mechanism. These results are similar to studies of virally transduced cells. Thus, infusion of cells with optimum engraftment potential could not compensate for the loss of donor cells due to immunogenicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085541     DOI: 10.1080/10245330500093468

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  14 in total

1.  Allogeneic bone marrow transplant in the absence of cytoreductive conditioning rescues mice with β-thalassemia major.

Authors:  Yongliang Huo; Jonathan R Lockhart; Shanrun Liu; Suean Fontenard; Mike Berlett; Thomas M Ryan
Journal:  Blood Adv       Date:  2017-11-28

2.  Molecular imaging of bone marrow mononuclear cell survival and homing in murine peripheral artery disease.

Authors:  Koen E A van der Bogt; Alwine A Hellingman; Maarten A Lijkwan; Ernst-Jan Bos; Margreet R de Vries; Juliaan R M van Rappard; Michael P Fischbein; Paul H Quax; Robert C Robbins; Jaap F Hamming; Joseph C Wu
Journal:  JACC Cardiovasc Imaging       Date:  2012-01

3.  Recent thymic emigrants are preferentially incorporated only into the depleted T-cell pool.

Authors:  Evan G Houston; Lauren E Higdon; Pamela J Fink
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

4.  Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart.

Authors:  Koen E A van der Bogt; Sonja Schrepfer; Jin Yu; Ahmad Y Sheikh; Grant Hoyt; Johannes A Govaert; Jeffrey B Velotta; Christopher H Contag; Robert C Robbins; Joseph C Wu
Journal:  Transplantation       Date:  2009-03-15       Impact factor: 4.939

5.  Transgene expression levels determine the immunogenicity of transduced hematopoietic grafts in partially myeloablated mice.

Authors:  Herena Eixarch; Alba Gómez; Elisabeth Kádár; Mónica George; Nuria Martínez; Carmen Espejo; Jordi Pétriz; Ramon Gimeno; Jordi Barquinero
Journal:  Mol Ther       Date:  2009-08-25       Impact factor: 11.454

6.  Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.

Authors:  Ryoko Araki; Masahiro Uda; Yuko Hoki; Misato Sunayama; Miki Nakamura; Shunsuke Ando; Mayumi Sugiura; Hisashi Ideno; Akemi Shimada; Akira Nifuji; Masumi Abe
Journal:  Nature       Date:  2013-01-09       Impact factor: 49.962

7.  Human and murine very small embryonic-like cells represent multipotent tissue progenitors, in vitro and in vivo.

Authors:  Aaron M Havens; Hongli Sun; Yusuke Shiozawa; Younghun Jung; Jingcheng Wang; Anjali Mishra; Yajuan Jiang; David W O'Neill; Paul H Krebsbach; Denis O Rodgerson; Russell S Taichman
Journal:  Stem Cells Dev       Date:  2014-02-04       Impact factor: 3.272

8.  Gender-dependent survival of allogeneic trophoblast stem cells in liver.

Authors:  Jessica Epple-Farmer; Bisrat G Debeb; Oliver Smithies; Bert Binas
Journal:  Cell Transplant       Date:  2009-04-29       Impact factor: 4.064

9.  Bioluminescence-based visualization of CD4 T cell dynamics using a T lineage-specific luciferase transgenic model.

Authors:  Joseph H Chewning; Kari J Dugger; Tandra R Chaudhuri; Kurt R Zinn; Casey T Weaver
Journal:  BMC Immunol       Date:  2009-08-03       Impact factor: 3.615

10.  Options for tracking GFP-Labeled transplanted myoblasts using in vivo fluorescence imaging: implications for tracking stem cell fate.

Authors:  Zhong Yang; Yaming Wang; Yanan Li; Qiang Liu; Qing Zeng; Xiaoyin Xu
Journal:  BMC Biotechnol       Date:  2014-06-12       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.